By Business/Source
Currency:CNY
2025/FY
Stock NameRevenueRatio
静脉介入、血管通路及其他产品322.95M50.10%
核心产品318.99M49.48%
Revenue from R & D services2.69M0.42%
By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
静脉介入、血管通路及其他产品322.95M50.10%
核心产品318.99M49.48%
Revenue from R & D services2.69M0.42%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China625.47M97.03%
Other countries and regions19.16M2.97%
